Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CBA Florida, Inc.CBAI · Entity 148644 | Co-Chief Executive Officer · 10% owner | June 04, 2020 | June 08, 2020 |
| CRYO CELL INTERNATIONAL INCCCEL · Entity 7400 | Director · Co-CEO · 10% owner | January 07, 2026 | January 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CBA Florida, Inc.
Report date June 04, 2020 · Filed June 08, 2020
Jointly reported with CRYO CELL INTERNATIONAL INC, PORTNOY DAVID
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,663,572 |
Reported balance
After 2020-06-04 transaction · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · 2020-06-04 · Sale · Disposed 530,000 · Balance 4,663,572 F2: Shares owned solely by David I. Portnoy. F4: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
| Common StockSEC Table I · non-derivative | Direct | 3,433,483 |
Reported balance
After 2020-06-05 transaction · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · 2020-06-05 · Sale · Disposed 1,230,089 · Balance 3,433,483 F2: Shares owned solely by David I. Portnoy. F4: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
| Common StockSEC Table I · non-derivative | Direct | 114,207,446 |
Reported balance
Holding disclosure · report date 2020-06-04 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 114,207,446 F1: Shares owned solely by Cryo-Cell International, Inc. F4: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
| Common StockSEC Table I · non-derivative | Direct | 5,614,932 |
Reported balance
Holding disclosure · report date 2020-06-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 5,614,932 F2: Shares owned solely by David I. Portnoy. F4: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
| Common StockSEC Table I · non-derivative | Direct | 4,061,770 |
Reported balance
Holding disclosure · report date 2020-06-04 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 4,061,770 F3: Shares owned solely by Mark L. Portnoy. F4: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares owned solely by Cryo-Cell International, Inc.
F2: Shares owned solely by David I. Portnoy.
F3: Shares owned solely by Mark L. Portnoy.
F4: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended.
CRYO CELL INTERNATIONAL INC
Report date January 07, 2026 · Filed January 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $3.89 · Expires 2031-01-07 | Direct | 50,000 |
Reported balance
After 2026-01-07 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2026-01-07 · Grant · Acquired 50,000 · Balance 50,000 F6: The stock options were granted pursuant to the Cryo-Cell 2022 Stock Incentive Plan and an individual award agreement. The options are divided into three equal tranches, each subject to both time-based vesting and stock-price performance conditions. One tranche vests after the first anniversary of the grant date and upon the Company's common stock achieving an average closing price of at least $6 per share over 20 consecutive trading days. One tranche vests after the second anniversary and upon achieving an average closing price of at least $8 per share over 20 consecutive trading days. One tranche vests after the third anniversary and upon achieving an average closing price of at least $10 per share over 20 consecutive trading days, in each case subject to the reporting person's continued service to the Company. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $3.89 · Expires 2031-01-07 | Direct | 25,000 |
Reported balance
After 2026-01-07 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2026-01-07 · Grant · Acquired 25,000 · Balance 25,000 F7: Stock options vest 1/3 upon issuance, 1/3 on January 7, 2027 and 1/3 on January 7, 2028. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $7.53 · Expires 2029-08-30 | Direct | 22,222 |
Reported balance
Holding disclosure · report date 2026-01-07 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 22,222 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $7.28 · Expires 2029-12-20 | Direct | 20,000 |
Reported balance
Holding disclosure · report date 2026-01-07 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 20,000 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $12.27 · Expires 2028-12-22 | Direct | 100,000 |
Reported balance
Holding disclosure · report date 2026-01-07 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 100,000 F2: Stock options will vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $4.77 · Expires 2028-01-03 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2026-01-07 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 25,000 F3: 8,750 stock options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $4.30 · Expires 2027-12-23 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2026-01-07 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 25,000 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $6.47 · Expires 2028-12-22 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2026-01-07 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 25,000 F4: Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $8.08 · Expires 2030-01-21 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2026-01-07 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 25,000 F5: Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027. |
| Common StockSEC Table I · non-derivative | Direct | 821,973 |
Reported balance
Holding disclosure · report date 2026-01-07 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 821,973 |
| Common StockSEC Table I · non-derivative | IndirectBy 401K | 42,266 |
Reported balance
Holding disclosure · report date 2026-01-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 42,266 |
| Common StockSEC Table I · non-derivative | IndirectBy Partnership | 71,529 |
Reported balance
Holding disclosure · report date 2026-01-07 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 71,529 F1: Shares of common stock held by Capital Asset Fund #1 Limited Partnership, as to which Mark Portnoy may be deemed beneficial owner as its general partner. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of common stock held by Capital Asset Fund #1 Limited Partnership, as to which Mark Portnoy may be deemed beneficial owner as its general partner.
F2: Stock options will vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term.
F3: 8,750 stock options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026.
F4: Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025.
F5: Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027.
F6: The stock options were granted pursuant to the Cryo-Cell 2022 Stock Incentive Plan and an individual award agreement. The options are divided into three equal tranches, each subject to both time-based vesting and stock-price performance conditions. One tranche vests after the first anniversary of the grant date and upon the Company's common stock achieving an average closing price of at least $6 per share over 20 consecutive trading days. One tranche vests after the second anniversary and upon achieving an average closing price of at least $8 per share over 20 consecutive trading days. One tranche vests after the third anniversary and upon achieving an average closing price of at least $10 per share over 20 consecutive trading days, in each case subject to the reporting person's continued service to the Company.
F7: Stock options vest 1/3 upon issuance, 1/3 on January 7, 2027 and 1/3 on January 7, 2028.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 07, 2026 Filed Jan 9, 2026 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 25,000 | $3.89 Strike: $3.89 | $97,250.00 |
DisclosureSEC source: 0001193125-26-009068 · ownership.xml · derivative · entry 12 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-01-07 F7 · derivative.exercise_date: Stock options vest 1/3 upon issuance, 1/3 on January 7, 2027 and 1/3 on January 7, 2028. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 50,000 | $3.89 Strike: $3.89 | $194,500.00 |
DisclosureSEC source: 0001193125-26-009068 · ownership.xml · derivative · entry 11 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-01-07 F6 · derivative.exercise_date: The stock options were granted pursuant to the Cryo-Cell 2022 Stock Incentive Plan and an individual award agreement. The options are divided into three equal tranches, each subject to both time-based vesting and stock-price performance conditions. One tranche vests after the first anniversary of the grant date and upon the Company's common stock achieving an average closing price of at least $6 per share over 20 consecutive trading days. One tranche vests after the second anniversary and upon achieving an average closing price of at least $8 per share over 20 consecutive trading days. One tranche vests after the third anniversary and upon achieving an average closing price of at least $10 per share over 20 consecutive trading days, in each case subject to the reporting person's continued service to the Company. Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 25,000 | $8.08 Strike: $8.08 | $202,000.00 |
DisclosureSEC source: 0000950170-25-008396 · ownership.xml · derivative · entry 10 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-01-21 F5 · derivative.exercise_date: Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027. Read SEC document |
| December 22, 2023 Filed Dec 28, 2023 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 25,000 | $6.47 Strike: $6.47 | $161,750.00 |
DisclosureSEC source: 0001209191-23-059921 · doc4.xml · derivative · entry 10 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-12-22 F7 · derivative.exercise_date: Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 22:26 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 25,000 | $4.77 Strike: $4.77 | $119,250.00 |
DisclosureSEC source: 0001209191-23-001972 · doc4.xml · derivative · entry 9 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-01-03 F5 · derivative.exercise_date: 11,250 options vest upon issuance, 11,250 options vest on 1/2/2024 and 2,500 options vest on 1/2/2025. Read SEC document |
| December 23, 2022 Filed Jan 6, 2023 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 25,000 | $4.30 Strike: $4.30 | $107,500.00 |
DisclosureSEC source: 0001209191-23-002381 · doc4.xml · derivative · entry 10 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-12-23 F6 · derivative.exercise_date: Pursuant to the executive's Employment Agreement effective December 1, 2022, stock options will be awarded and will vest immediately if the price of the Company's stock reaches $8.00 per share during the five-year option term. Read SEC document |
| August 25, 2022 Filed Aug 29, 2022 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionStock Option · Derivative | 59,459 | $3.14 Strike: $3.14 | $186,701.26 |
DisclosureSEC source: 0001209191-22-047881 · doc4.xml · derivative · entry 4 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 59,459 shares Expires 2026-04-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2022 Filed Aug 29, 2022 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionCommon Stock | 59,459 | $3.14 | $186,701.26 |
DisclosureSEC source: 0001209191-22-047881 · doc4.xml · nonDerivative · entry 3 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 821,973 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2022 Filed Apr 14, 2022 20:00 UTC Amendment | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 100,000 | $12.27 Strike: $12.27 | $1,227,000.00 |
DisclosureSEC source: 0001209191-22-024405 · doc4a.xml · derivative · entry 11 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-12-22 F4 · kind: The stock options are subject to the approval of the 2022 Equity Incentive Plan, which vote is expected to occur at the Company's 2022 Annual Meeting. F6 · derivative.exercise_date: Stock options vest immediately when the price of the Company's stock reaches $25.00 per share during the seven-year option term. Read SEC document |
| April 08, 2022 Filed Apr 14, 2022 20:00 UTC Amendment | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 20,000 | $13.50 Strike: $13.50 | $270,000.00 |
DisclosureSEC source: 0001209191-22-024405 · doc4a.xml · derivative · entry 10 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2024-12-22 F4 · kind: The stock options are subject to the approval of the 2022 Equity Incentive Plan, which vote is expected to occur at the Company's 2022 Annual Meeting. F5 · derivative.exercise_date: One-third of the stock options will vest on December 22, 2022, one-third will vest on January 22, 2023 and one-third on January 22, 2024. Read SEC document |
| December 22, 2021 Filed Dec 27, 2021 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 100,000 | $12.27 Strike: $12.27 | $1,227,000.00 |
DisclosureSEC source: 0001209191-21-071279 · doc4.xml · derivative · entry 9 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-12-21 F4 · derivative.exercise_date: Stock options vest immediately if the price of the Company's stock reaches $25.00 per share during the seven-year option term. Read SEC document |
| December 22, 2021 Filed Dec 27, 2021 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 20,000 | $12.27 Strike: $12.27 | $245,400.00 |
DisclosureSEC source: 0001209191-21-071279 · doc4.xml · derivative · entry 8 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2024-12-21 F3 · derivative.exercise_date: Stock options fully vest upon issuance. Read SEC document |
| December 22, 2021 Filed Feb 8, 2022 22:00 UTC Amendment | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 100,000 | $12.27 Strike: $12.27 | $1,227,000.00 |
DisclosureSEC source: 0001209191-22-007783 · doc4a.xml · derivative · entry 9 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-12-22 F4 · derivative.exercise_date: Stock options vest immediately if the price of the Company's stock reaches $25.00 per share during the seven-year option term. Read SEC document |
| December 22, 2021 Filed Feb 8, 2022 22:00 UTC Amendment | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 20,000 | $13.50 Strike: $13.50 | $270,000.00 |
DisclosureSEC source: 0001209191-22-007783 · doc4a.xml · derivative · entry 8 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2024-12-22 F3 · derivative.exercise_date: The reporting person is amending his Form 4 filed on December 27, 2021 to correct an inadvertent error in reporting the exercise price of the Incentive Stock Option due to the reporting person being a 10% shareholder. Stock options vest 1/3 on the date of grant, 1/3 on December 22, 2022 and 1/3 on December 22, 2023. Read SEC document |
| December 22, 2021 Filed Apr 14, 2022 20:00 UTC Amendment | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Disposition to issuerStock Option · Derivative | 100,000 | $12.27 Strike: $12.27 | $1,227,000.00 |
DisclosureSEC source: 0001209191-22-024405 · doc4a.xml · derivative · entry 9 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2028-12-22 F3 · kind: On April 8, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. Read SEC document |
| December 22, 2021 Filed Apr 14, 2022 20:00 UTC Amendment | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Disposition to issuerStock Option · Derivative | 20,000 | $13.50 Strike: $13.50 | $270,000.00 |
DisclosureSEC source: 0001209191-22-024405 · doc4a.xml · derivative · entry 8 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2024-12-22 Read SEC document |
| August 24, 2021 Filed Aug 26, 2021 21:05 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionStock Option · Derivative | 67,816 | $2.90 Strike: $2.90 | $196,666.40 |
DisclosureSEC source: 0001209191-21-053499 · doc4.xml · derivative · entry 5 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 67,816 shares Expires 2021-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2021 Filed Aug 26, 2021 21:05 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Tax withholdingCommon Stock | 25,500 | $10.50 | $267,750.00 |
DisclosureSEC source: 0001209191-21-053499 · doc4.xml · nonDerivative · entry 4 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 762,014 F2 · shares: Shares of common stock were withheld by the Company as payment for the exercise price of the common stock and associated tax liabilities. Read SEC document |
| August 24, 2021 Filed Aug 26, 2021 21:05 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionCommon Stock | 67,816 | $2.90 | $196,666.40 |
DisclosureSEC source: 0001209191-21-053499 · doc4.xml · nonDerivative · entry 3 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 787,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2021 Filed May 26, 2021 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionStock Option · Derivative | 32,184 | $2.90 Strike: $2.90 | $93,333.60 |
DisclosureSEC source: 0001209191-21-035965 · doc4.xml · derivative · entry 6 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,816 Underlying: Common Stock · 100,000 shares Expires 2021-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2021 Filed May 26, 2021 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionStock Option · Derivative | 200,000 | $1.72 Strike: $1.72 | $344,000.00 |
DisclosureSEC source: 0001209191-21-035965 · doc4.xml · derivative · entry 5 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires 2021-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2021 Filed May 26, 2021 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionCommon Stock | 32,184 | $2.90 | $93,333.60 |
DisclosureSEC source: 0001209191-21-035965 · doc4.xml · nonDerivative · entry 4 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 719,698 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2021 Filed May 26, 2021 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionCommon Stock | 200,000 | $1.72 | $344,000.00 |
DisclosureSEC source: 0001209191-21-035965 · doc4.xml · nonDerivative · entry 3 Portnoy Mark L. · CIK 0001529249 · Director · Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 687,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 21:08 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 5,000 | $8.25 | $41,250.00 |
DisclosureSEC source: 0000899243-20-020559 · doc4.xml · nonDerivative · entry 3 Portnoy Mark L. · CIK 0001529249 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 487,514 Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 21:08 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 4,000 | $8.25 | $33,000.00 |
DisclosureSEC source: 0000899243-20-020559 · doc4.xml · nonDerivative · entry 1 Portnoy Mark L. · CIK 0001529249 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 42,266 Read SEC document |
| July 20, 2020 Filed Jul 20, 2020 21:34 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 500 | $8.00 | $4,000.00 |
DisclosureSEC source: 0000899243-20-019697 · doc4.xml · nonDerivative · entry 3 Portnoy Mark L. · CIK 0001529249 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 38.266 Read SEC document |
| July 16, 2020 Filed Jul 20, 2020 21:34 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 131 | $7.60 | $995.60 |
DisclosureSEC source: 0000899243-20-019697 · doc4.xml · nonDerivative · entry 2 Portnoy Mark L. · CIK 0001529249 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 37,766 Read SEC document |
| July 16, 2020 Filed Jul 20, 2020 21:34 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 1,250 | $8.00 | $10,000.00 |
DisclosureSEC source: 0000899243-20-019697 · doc4.xml · nonDerivative · entry 1 Portnoy Mark L. · CIK 0001529249 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 37,635 Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 21:34 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 200 | $7.51 | $1,502.00 |
DisclosureSEC source: 0000899243-20-019195 · doc4.xml · nonDerivative · entry 1 Portnoy Mark L. · CIK 0001529249 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36.385 Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:23 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 5,000 | $8.30 | $41,500.00 |
DisclosureSEC source: 0000899243-20-016673 · doc4.xml · nonDerivative · entry 14 Portnoy Mark L. · CIK 0001529249 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 36,185 Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:23 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 1,400 | $7.50 | $10,500.00 |
DisclosureSEC source: 0000899243-20-016673 · doc4.xml · nonDerivative · entry 13 Portnoy Mark L. · CIK 0001529249 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 31,185 Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:23 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 3,330 | $8.25 | $27,472.50 |
DisclosureSEC source: 0000899243-20-016673 · doc4.xml · nonDerivative · entry 12 Portnoy Mark L. · CIK 0001529249 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 29,785 Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:23 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 732 | $6.99 | $5,116.68 |
DisclosureSEC source: 0000899243-20-016673 · doc4.xml · nonDerivative · entry 11 Portnoy Mark L. · CIK 0001529249 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 26,455 Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:23 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 268 | $6.98 | $1,870.64 |
DisclosureSEC source: 0000899243-20-016673 · doc4.xml · nonDerivative · entry 10 Portnoy Mark L. · CIK 0001529249 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 25,723 Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:23 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 1,500 | $7.99 | $11,985.00 |
DisclosureSEC source: 0000899243-20-016673 · doc4.xml · nonDerivative · entry 9 Portnoy Mark L. · CIK 0001529249 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 25,455 Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:23 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 1,400 | $7.30 | $10,220.00 |
DisclosureSEC source: 0000899243-20-016673 · doc4.xml · nonDerivative · entry 8 Portnoy Mark L. · CIK 0001529249 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 23,955 Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:23 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 100 | $6.50 | $650.00 |
DisclosureSEC source: 0000899243-20-016673 · doc4.xml · nonDerivative · entry 7 Portnoy Mark L. · CIK 0001529249 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 22,555 Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:23 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 100 | $6.31 | $631.00 |
DisclosureSEC source: 0000899243-20-016673 · doc4.xml · nonDerivative · entry 6 Portnoy Mark L. · CIK 0001529249 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 22,455 Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:23 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 100 | $7.10 | $710.00 |
DisclosureSEC source: 0000899243-20-016673 · doc4.xml · nonDerivative · entry 5 Portnoy Mark L. · CIK 0001529249 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 22,355 Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:23 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 763 | $7.50 | $5,722.50 |
DisclosureSEC source: 0000899243-20-016673 · doc4.xml · nonDerivative · entry 4 Portnoy Mark L. · CIK 0001529249 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 22,255 Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:23 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 1,237 | $7.40 | $9,153.80 |
DisclosureSEC source: 0000899243-20-016673 · doc4.xml · nonDerivative · entry 3 Portnoy Mark L. · CIK 0001529249 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 21,492 Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:23 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 1,700 | $7.00 | $11,900.00 |
DisclosureSEC source: 0000899243-20-016673 · doc4.xml · nonDerivative · entry 2 Portnoy Mark L. · CIK 0001529249 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 20,255 Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:23 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 500 | $6.98 | $3,490.00 |
DisclosureSEC source: 0000899243-20-016673 · doc4.xml · nonDerivative · entry 1 Portnoy Mark L. · CIK 0001529249 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 18,555 Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 21:21 UTC | CBA Florida, Inc. CBAI · Entity 148644 | SaleCommon Stock | 1,230,089 | $0.01 | $9,102.66 |
DisclosureSEC source: 0000899243-20-015642 · doc4.xml · nonDerivative · entry 5 CRYO CELL INTERNATIONAL INC · CIK 0000862692 · 10% owner PORTNOY DAVID · CIK 0001315416 · Co-Chief Executive Officer · 10% owner Portnoy Mark L. · CIK 0001529249 · Co-Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,433,483 F2 · shares: Shares owned solely by David I. Portnoy. F2 · balance_after: Shares owned solely by David I. Portnoy. F4 · balance_after: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 04, 2020 Filed Jun 8, 2020 21:21 UTC | CBA Florida, Inc. CBAI · Entity 148644 | SaleCommon Stock | 530,000 | $0.01 | $4,028.00 |
DisclosureSEC source: 0000899243-20-015642 · doc4.xml · nonDerivative · entry 4 CRYO CELL INTERNATIONAL INC · CIK 0000862692 · 10% owner PORTNOY DAVID · CIK 0001315416 · Co-Chief Executive Officer · 10% owner Portnoy Mark L. · CIK 0001529249 · Co-Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,663,572 F2 · shares: Shares owned solely by David I. Portnoy. F2 · balance_after: Shares owned solely by David I. Portnoy. F4 · balance_after: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 21:04 UTC | CBA Florida, Inc. CBAI · Entity 148644 | SaleCommon Stock | 1,024,416 | $0.01 | $7,580.68 |
DisclosureSEC source: 0000899243-20-014923 · doc4.xml · nonDerivative · entry 5 CRYO CELL INTERNATIONAL INC · CIK 0000862692 · 10% owner PORTNOY DAVID · CIK 0001315416 · Co-Chief Executive Officer · 10% owner Portnoy Mark L. · CIK 0001529249 · Co-Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,193,572 F2 · shares: Shares owned solely by David I. Portnoy. F2 · balance_after: Shares owned solely by David I. Portnoy. F4 · balance_after: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2020 Filed Jun 2, 2020 21:04 UTC | CBA Florida, Inc. CBAI · Entity 148644 | SaleCommon Stock | 603,649 | $0.01 | $4,648.10 |
DisclosureSEC source: 0000899243-20-014923 · doc4.xml · nonDerivative · entry 4 CRYO CELL INTERNATIONAL INC · CIK 0000862692 · 10% owner PORTNOY DAVID · CIK 0001315416 · Co-Chief Executive Officer · 10% owner Portnoy Mark L. · CIK 0001529249 · Co-Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,217,988 F2 · shares: Shares owned solely by David I. Portnoy. F2 · balance_after: Shares owned solely by David I. Portnoy. F4 · balance_after: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 07, 2020 Filed May 14, 2020 20:00 UTC | CBA Florida, Inc. CBAI · Entity 148644 | SaleCommon Stock | 1,649,999 | $0.01 | $12,209.99 |
DisclosureSEC source: 0000899243-20-013070 · doc4.xml · nonDerivative · entry 5 CRYO CELL INTERNATIONAL INC · CIK 0000862692 · 10% owner PORTNOY DAVID · CIK 0001315416 · Co-Chief Executive Officer · 10% owner Portnoy Mark L. · CIK 0001529249 · Co-Chief Executive Officer · 10% owner Gaines George · CIK 0001529399 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 779,138 F4 · shares: Shares owned solely by George Gaines. F4 · balance_after: Shares owned solely by George Gaines. F5 · balance_after: Messrs. Portnoy, Portnoy and Gaines, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 06, 2020 Filed May 14, 2020 20:00 UTC | CBA Florida, Inc. CBAI · Entity 148644 | SaleCommon Stock | 586,575 | $0.01 | $4,340.66 |
DisclosureSEC source: 0000899243-20-013070 · doc4.xml · nonDerivative · entry 4 CRYO CELL INTERNATIONAL INC · CIK 0000862692 · 10% owner PORTNOY DAVID · CIK 0001315416 · Co-Chief Executive Officer · 10% owner Portnoy Mark L. · CIK 0001529249 · Co-Chief Executive Officer · 10% owner Gaines George · CIK 0001529399 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,429,137 F4 · shares: Shares owned solely by George Gaines. F4 · balance_after: Shares owned solely by George Gaines. F5 · balance_after: Messrs. Portnoy, Portnoy and Gaines, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 05, 2020 Filed May 6, 2020 20:00 UTC | CBA Florida, Inc. CBAI · Entity 148644 | SaleCommon stock | 945,955 | $0.01 | $7,000.07 |
DisclosureSEC source: 0000899243-20-012129 · doc4.xml · nonDerivative · entry 6 CRYO CELL INTERNATIONAL INC · CIK 0000862692 · 10% owner PORTNOY DAVID · CIK 0001315416 · Co-Chief Executive Officer · 10% owner Portnoy Mark L. · CIK 0001529249 · Co-Chief Executive Officer · 10% owner Gaines George · CIK 0001529399 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,015,712 F4 · shares: Shares owned solely by George Gaines. F4 · balance_after: Shares owned solely by George Gaines. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.